H, Z., H, L., Y, L., C, W., Q, W., I, N., . . . S, G. (2016). Safety and efficacy of paliperidone extended-release in Chinese patients with schizophrenia: A 24-week, open-label extension of a randomized, double-blind, placebo-controlled study. Dove Medical Press.
Cita Chicago Style (17a ed.)H, Zhang, et al. Safety and Efficacy of Paliperidone Extended-release in Chinese Patients with Schizophrenia: A 24-week, Open-label Extension of a Randomized, Double-blind, Placebo-controlled Study. Dove Medical Press, 2016.
Cita MLA (8a ed.)H, Zhang, et al. Safety and Efficacy of Paliperidone Extended-release in Chinese Patients with Schizophrenia: A 24-week, Open-label Extension of a Randomized, Double-blind, Placebo-controlled Study. Dove Medical Press, 2016.
Precaución: Estas citas no son 100% exactas.